Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Implementation of a Trans-tailored Harm Reduction Service for Transgender Persons in Relation to chemsEX and Substance Use (iT-REX)

NCT07512856 is registered in ClinicalTrials.gov with Institute of HIV Research and Innovation Foundation, Thailand as lead sponsor.

NCT NCT07512856
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07512856 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Implementation of a Trans-tailored Harm Reduction Service for Transgender Persons in Relation to chemsEX and Substance Use (iT-REX)
Lead sponsor
Institute of HIV Research and Innovation Foundation, Thailand
Phase
Not applicable
Overall status
Recruiting
Start date
February 1, 2024
Completion date
February 1, 2028
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemsex, hiv prevention, mental health disorders, sexually transmitted infections (stis), substance use